A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.

Autor: Opoku, Nicholas O.1 (AUTHOR), Doe, Felix2 (AUTHOR), Dubben, Bettina3 (AUTHOR), Fetcho, Nicole4 (AUTHOR), Fischer, Kerstin4 (AUTHOR), Fischer, Peter U.4 (AUTHOR), Gordor, Shelter1 (AUTHOR), Goss, Charles W.5 (AUTHOR), Gyasi, Michael E.6 (AUTHOR), Hoerauf, Achim3 (AUTHOR), Hong, Augustine R.7 (AUTHOR), Kanza, Eric1,8 (AUTHOR), King, Christopher L.9 (AUTHOR), Laryea, Ruth1 (AUTHOR), Lew, Daphne5 (AUTHOR), Seidu, Mahmood A.10 (AUTHOR), Weil, Gary J.4 (AUTHOR) gweil@dom.wustl.edu
Zdroj: PLoS Neglected Tropical Diseases. 5/19/2023, Vol. 16 Issue 5, p1-18. 18p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje